LDH as a Biochemical Biomarker to Predict Organ Failure in the Emergency Department Setting
NCT ID: NCT01937676
Last Updated: 2016-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1250 participants
OBSERVATIONAL
2013-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Endothelial Cell Specific Molecule-1 (ESM-1): a Novel Biomarker for ARDS Endothelial Injury
NCT03296761
Cardiovascular Biomarkers and Lung Edema in Severe Burns Patients
NCT03271268
Arterial pH Selectively Predicts Intensive Care Unit Transfer From the Emergency Department in Obese Patients With Acute Dyspnea
NCT03239730
Randomized Controlled Pilot Study of Methods for Identifying Patients At High Risk of Worsening in the Adult Emergency Department
NCT05813431
Biomarkes Of Job STRess In Emergency Senior Physicians - Detection of Stressful Events
NCT04334083
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adults admitted to ER
All adult patients admitted to emergency department during the study period.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to emergency department, Karlstad Central Hospital, Sweden
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fredrik Helliksson
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mathias Karlsson, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Karolinska
Jan Wernerman, MD, Prof
Role: STUDY_DIRECTOR
Karolinska
Lars Wiklund, MD, Prof
Role: STUDY_DIRECTOR
Uppsala University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karlstad Central Hospital
Karlstad, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
K3-akuten
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.